Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Helix BioPharma Corp

+ Add to Watchlist

HBP:GR

1.217 EUR 0.012 1.00%

As of 14:45:35 ET on 03/27/2015.

Snapshot for Helix BioPharma Corp (HBP)

Open: 1.138 Day's Range: 1.138 - 1.262 Volume: 0
Previous Close: 1.205 52wk Range: 0.788 - 1.540 1-Yr Rtn: +27.43%

Stock Chart for HBP

No chart data available.
  • HBP:GR 1.217
  • 1D
  • 1M
  • 1Y
1.205
Interactive HBP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HBP

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 92.37
Shares Outstanding (M) 75.90
30 Day Average Volume 701
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 06/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HBP

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for HBP

Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. The Company is developing products for the prevention and treatment of cancer based on its proprietary technologies.

Robert A VerhagenPresident/CEOPhotios Michalargias "Frank"CFO/Secretary
Heman ChaoChief Scientific Officer
More Company Profile & Key Executives for HBP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil